Quantinuum disclosed on May 26 that it is targeting a valuation of up to $12.7 billion in a U.S. initial public offering and plans to raise up to $1.05 billion by selling roughly 21.05 million shares priced between $45 and $50 each.
The company said the IPO would list on the Nasdaq under the symbol QNT, with J.P. Morgan and Morgan Stanley serving as joint lead active book‑running managers. Honeywell is set to retain substantial influence after the offering, with about 49.1% of combined voting power once the deal closes.
The numbers are striking against Quantinuum’s recent operating results. In 2025 the company reported a net loss of $192.6 million on revenue of $30.9 million; a year earlier it posted a net loss of $144.1 million on revenue of $23 million. Quantinuum has told investors that it raised funds at a $10 billion valuation in its most recent financing round this past September.
The IPO comes as the federal government moves to deepen its position in quantum computing: the administration has said it will take $2 billion in equity stakes across nine quantum‑computing companies and included a $100 million grant for Quantinuum. That financial backing is likely to sharpen scrutiny of whether public investors will value government support and long‑term promise more highly than current revenue and losses.
Quantinuum traces its corporate arc to 2021, when it formed after a separation from Honeywell and a merger with Cambridge Quantum. Honeywell is expected to remain a customer and partner after the IPO, a tie that helps explain its near‑majority voting stake in the public company.
The market for quantum computing is alive with interest but still confronting hard technical limits. The company itself and industry observers note that high error rates in current quantum hardware constrain practical performance, meaning large sums of capital are needed just to move from laboratory demonstrations to commercially useful machines.
That gap between promise and practice creates the central tension of Quantinuum’s offering. The firm is chasing a valuation well above the $10 billion it secured last fall even as it operates at sizable losses and sells a technology investors recognize as nascent and technically challenging. The government grants and equity commitments reduce some investor risk, but they also raise questions about how much of the company’s market value rests on public support rather than private demand.
Under the terms disclosed, the IPO would put about 21.05 million shares into the market at $45 to $50 apiece, yielding up to $1.05 billion before underwriting fees and expenses. The proceeds, and the transition to a public market, will give Quantinuum new capital to develop hardware, software and error‑reduction techniques that the industry says are critical to making quantum computing commercially viable.
If investors accept the gap between current financials and future potential, Quantinuum will gain both funding and a public valuation that could accelerate hiring and R&D. If they balk at a high price for a business still wrestling with technical hurdles and steep losses, the offering will be a test of investor appetite for speculative, government‑backed bets in cutting‑edge computing. The listing on Nasdaq under QNT will be the clearest signal: it will show whether the market is ready to pay a premium for quantum’s promise or insists that performance come first.
